Literature DB >> 18191952

Antigen inhalation induces mast cells and eosinophils infiltration in the guinea pig esophageal epithelium involving histamine-mediated pathway.

Shaoyong Yu1, Edward Stahl, Qing Li, Ann Ouyang.   

Abstract

Antigen challenge in sensitized guinea pig esophagus in vitro induces mast cell degranulation and histamine release. This study tests the hypothesis that antigen inhalation in vivo induces infiltration of the esophageal epithelium by mast cells and eosinophils via a histamine pathway. Actively sensitized guinea pigs were exposed to inhaled 0.1% ovalbumin. One or 24 h after inhalation exposure, the esophagus was processed for immunofluorescent staining of mast cell tryptase and eosinophil major basic protein (MBP). Additional animals were pretreated with thioperamide, a histamine H4/H3 receptor antagonist. Total tryptase- and MBP-labeled cells and percent of positive cells in the epithelial layer were counted. The total number of mast cells was unchanged after inhalation challenge, but the percentage in the epithelium increased 1 h after challenge. The total number of eosinophils increased 1 h after challenge, and the percentage migrating to the epithelium increased by 24 h after challenge. Mast cell migration into the mucosal epithelium preceded that of eosinophils. Thioperamide inhibited mast cell and eosinophil migration. In conclusion, antigen inhalation in sensitized animals induces mast cells and eosinophils to infiltrate in the esophageal epithelium via histamine-mediated mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18191952     DOI: 10.1016/j.lfs.2007.12.002

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  15 in total

Review 1.  Histamine H₄ receptors in the gastrointestinal tract.

Authors:  A Deiteren; J G De Man; P A Pelckmans; B Y De Winter
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

Review 2.  The role of histamine H4 receptor in immune and inflammatory disorders.

Authors:  E Zampeli; E Tiligada
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

Review 3.  Recent advances in the pathological understanding of eosinophilic esophagitis.

Authors:  Antonella Cianferoni; Jonathan M Spergel; Amanda Muir
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-10-15       Impact factor: 3.869

4.  Allergen challenge sensitizes TRPA1 in vagal sensory neurons and afferent C-fiber subtypes in guinea pig esophagus.

Authors:  Zhenyu Liu; Youtian Hu; Xiaoyun Yu; Jiefeng Xi; Xiaoming Fan; Chung-Ming Tse; Allen C Myers; Pankaj J Pasricha; Xingde Li; Shaoyong Yu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-01-15       Impact factor: 4.052

Review 5.  Allergic mechanisms in eosinophilic esophagitis.

Authors:  Joshua B Wechsler; Paul J Bryce
Journal:  Gastroenterol Clin North Am       Date:  2014-03-22       Impact factor: 3.806

Review 6.  Targeting eosinophils in allergy, inflammation and beyond.

Authors:  Patricia C Fulkerson; Marc E Rothenberg
Journal:  Nat Rev Drug Discov       Date:  2013-01-21       Impact factor: 84.694

7.  Increased acid responsiveness in vagal sensory neurons in a guinea pig model of eosinophilic esophagitis.

Authors:  Youtian Hu; Zhenyu Liu; Xiaoyun Yu; Pankaj J Pasricha; Bradley J Undem; Shaoyong Yu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-29       Impact factor: 4.052

8.  Intraluminal acid activates esophageal nodose C fibers after mast cell activation.

Authors:  Shizhong Zhang; Zhenyu Liu; Andrea Heldsinger; Chung Owyang; Shaoyong Yu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-21       Impact factor: 4.052

9.  Prostaglandin D2 receptor D-type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus.

Authors:  S Zhang; X Wu; S Yu
Journal:  Dis Esophagus       Date:  2013-10-25       Impact factor: 3.429

Review 10.  Cough reflex sensitization from esophagus and nose.

Authors:  Michal Hennel; Mariana Brozmanova; Marian Kollarik
Journal:  Pulm Pharmacol Ther       Date:  2015-10-21       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.